Email this article 
Successful treatment of the Irvine-Gass syndrome with Nevanac
- Authors: Ro M.B.1, Ignatyev S.A.1, Alekseyev I.B.2, Korchuganova Y.A.1
-
Affiliations:
- Ophthalmology Clinic, Department of Health in Moscow
- Issue: Vol 6, No 4 (2013)
- Pages: 69-72
- Section: Articles
- Submitted: 24.06.2015
- Published: 15.12.2013
- URL: https://journals.eco-vector.com/ov/article/view/369
- DOI: https://doi.org/10.17816/OV2013469-72
- ID: 369
Cite item
Full Text
Abstract
The Authors describe a clinical case of the use of Nevanac - a medication from NSAID group in the successful treatment of cystoid macular edema caused by cataract extraction (Irvine-Gass syndrome).
About the authors
Marina Borisovna Ro
Ophthalmology Clinic, Department of Health in Moscow
Email: marinaro-66@mail.ru
ophthalmologist
Sergey Aleksandrovich Ignatyev
Ophthalmology Clinic, Department of Health in Moscow
Email: ignatievokb@gmail.com
candidate of medical science, deputy chief medical officer for outpatient work
Igor Borisovich Alekseyev
Email: ialekseev63@mail.ru
doctor of medical science, professor
Yelena Aleksandrovna Korchuganova
Ophthalmology Clinic, Department of Health in Moscow
References
- Астахов С. Ю., Гобеджишвили М. В. Послеоперационный макулярный отек, синдром Ирвина-Гасса // Клиническая офтальмология. - 2010. - Т. 11, № 1. - С. 5-8
- Hariprasad S. M., Akduman L., Clever J. A., et al. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1 % // Clin. Ophthalmol. - 2009. - Vol. 3. - P. 147-154.
- Hariprasad S. M., Callanan D., et al. Cystoid and diabetic macular edema treated with Nepafenac 0,1 % // of Ocular Pharmacology and Therapeutics. - Vol. 23. - P. 585-590.
- Tsilimbaris M. K. et al. Macular Edema and Cataract Surgery // Cataract Surgery / Farhan Husain Zaidi, (ed.). - Croatia (Rijeka), InTech, 2013. - 432 p.
- Miyake K., Ota I., Miyake G., Numaga J. Nepafenac 0.1 % versus fluorometholone 0.1 % for preventing cystoid macular edema after cataract surgery // J. Cataract Refract. Surg. - 2011. - Vol. 37. - P. 1581-1588.
- Nardi M., Lobo C., Bereczki A., et al. Analgesic and anti-inflammatory effectiveness of nepafenac 0.1 % for cataract surgery // Clinical Ophthalmology. - 2007. - Vol. 1 (4). - P. 527-533.
- Singh Rishi, Alpern Louis et al. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy // Clin. Ophthalmol. - 2012. - Vol. 6. - P. 1259-1269.
- Warren K. A., Fox J. E. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients // Retina. - 2008. - Vol. 28, N 10. - P. 1427-1434.
- Wolf E. J., Braunstein A., Shih C., Braunstein R. E. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac // J. Cataract Refract. Surg. - 2007. - Vol. 33, N 9. - P. 1546-1549.
Supplementary files
